Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cyclizine 30mg/5ml oral liquid
0406000F0AAAZAZ
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclizine 62.5mg/5ml oral liquid
0406000F0AAAUAU
|
Cyclizine hydrochloride | Cyclizine hydrochloride | Central Nervous System | No data available |
|
Cyclo-Progynova 1mg tablets
0604011L0BCAAAB
|
Cyclo-Progynova | Estradiol with progestogen | Endocrine System | No data available |
|
Cyclohaler
21011000610
|
Cyclohaler | Other Appliances | Appliances | No data available |
|
Cyclomen 50mg capsules
0607020C0BCAAAE
|
Cyclomen | Danazol | Endocrine System | No data available |
|
Cyclopenthiazide 500microgram tablets
0202010J0AAAAAA
|
Cyclopenthiazide | Cyclopenthiazide | Cardiovascular System | No data available |
|
Cyclophosphamide 100mg/5ml oral liquid
0801010H0AAARAR
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 1g powder for solution for injection vials
0801010H0AAADAD
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 200mg inj vials
0801010H0AAABAB
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 25mg tablets
0801010H0AAAKAK
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 25mg/5ml oral liquid
0801010H0AAAPAP
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 35mg/5ml oral liquid
0801010H0AAAMAM
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 40mg/5ml oral liquid
0801010H0AAAVAV
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 500mg inj vials
0801010H0AAACAC
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 50mg/5ml oral liquid
0801010H0AAANAN
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyclophosphamide 75mg/5ml oral liquid
0801010H0AAAQAQ
|
Cyclophosphamide | Cyclophosphamide | Malignant Disease and Immunosuppression | No data available |
|
Cyklo-f Heavy Period Relief 500mg tablets
0211000P0BDAAAC
|
Cyklo-f Heavy Period Relief | Tranexamic acid | Cardiovascular System | No data available |
|
Cymaclear 1.5g/5ml liquid
0704030G0BHAAAX
|
Cymaclear (Potassium citrate) | Potassium citrate | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cymalon Cranberry extract 200mg tablets
091200000BFQTA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Cymalon effervescent granules 6.76g sachets
0704030J0BCAAAI
|
Cymalon (Sodium citrate) | Sodium citrate | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cymevene 250mg capsules
0503022D0BBABAC
|
Cymevene | Ganciclovir | Infections | No data available |
|
Cymevene 500mg capsules
0503022D0BBACAD
|
Cymevene | Ganciclovir | Infections | No data available |
|
Cymevene 500mg pdr for concentrate for inf vials
0503022D0BBAAAA
|
Cymevene | Ganciclovir | Infections | No data available |
|
Cynara Artichoke 320mg capsules
091200000BERZA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Cynril 1.2mg lozenges with integral oromucosal applicator
0407020A0BWAEAN
|
Cynril | Fentanyl | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.